Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1). (Q47621653)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1).	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

title

Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1). (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

main subject

trastuzumab

1 reference

based on heuristic

inferred from title

author name string

Matthew Sung

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Xingzhi Tan

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Bingwen Lu

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Jonathan Golas

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Christine Hosselet

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Fang Wang

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Laurie Tylaska

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Lindsay King

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Dahui Zhou

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Russell Dushin

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Jeremy S Myers

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Edward Rosfjord

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Judy Lucas

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Hans-Peter Gerber

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

Frank Loganzo

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

publication date

20 October 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

published in

Molecular Cancer Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

volume

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

page(s)

243-253

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

cites work

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1158/0008-5472.CAN-08-1776

Identifiers

DOI

10.1158/1535-7163.MCT-17-0403

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

PubMed publication ID

29054985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

29054985

retrieved

4 February 2018

reference URL

http://europepmc.org/abstract/MED/29054985

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47621653&oldid=1647496007"